or Try an Advanced Search...

    Drug Therapies Stocks List

    Symbol Grade Name % Change
    TKNO B Alpha Teknova, Inc. -4.65
    XBIO C Xenetic Biosciences, Inc. -1.00
    HROW D Harrow Health, Inc. 2.71
    KAPA D Kairos Pharma, Ltd. 1.37
    ASND F Ascendis Pharma A/S -0.03
    CLSD F Clearside Biomedical, Inc. -0.48
    MRVI F Maravai LifeSciences Holdings, Inc. 2.70
    NLSP F NLS Pharmaceutics Ltd. 1.82
    PXMD F PaxMedica, Inc. -50.11
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Biology Biopharmaceutical Products Medicine Molecular Diagnostics Ophthalmology Pharmaceutical Products Pharmacy Acid Acute Myeloid Leukemia Adhd Adverum Biotechnologies Amphetamine Anemia Antibody Assay Development Services Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Drug Therapies stocks.

    Symbol Grade Name Weight
    MEDI D Harbor Health Care ETF 17.04
    JFWD B Jacob Funds Inc. Jacob Forward ETF 7.97
    SYNB D Putnam BioRevolution ETF 3.64
    FFTY A Innovator IBD 50 Fund ETF 2.95
    HRTS D Tema Cardiovascular and Metabolic ETF 2.88
    View all Drug Therapies ETFs...
    Compare ETFs
    Compare FFTY to HRTS Compare JFWD to FFTY Compare MEDI to FFTY

        Drug Therapies Stocks Recent News

        Date Stock Title
        Nov 21 HROW Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
        Nov 20 HROW Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
        Nov 20 MRVI Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
        Nov 18 NLSP NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
        Nov 16 HROW Harrow: Spotlight On IHEEZO
        Nov 15 CLSD All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
        Nov 15 HROW Harrow Announces Participation in Upcoming Investor Conferences
        Nov 15 CLSD Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 HROW Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
        Nov 15 ASND Ascendis Pharma A/S (ASND) Q3 2024 Earnings Call Transcript
        Nov 14 ASND Ascendis Pharma GAAP EPS of -€1.72, revenue of €57.83M
        Nov 14 ASND Ascendis Pharma Reports Third Quarter 2024 Financial Results
        Nov 14 HROW Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript
        Nov 14 HROW Harrow, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Biology Biopharmaceutical Products Medicine Molecular Diagnostics Ophthalmology Pharmaceutical Products Pharmacy Acid Acute Myeloid Leukemia Adhd Adverum Biotechnologies Amphetamine Anemia Antibody Assay Development Services Attention Deficit Hyperactivity Disorder Autism Spectrum Disorder
        Drug Therapies

        Drug therapies, also known as pharmacotherapy, are treatments that involve the use of medications to treat a variety of medical conditions. These medications can be used to treat physical illnesses, mental health disorders, and even addiction. Drug therapies can be used alone or in combination with other treatments, such as psychotherapy, to provide the best possible outcome for the patient.

        Browse All Tags